APA (7th ed.) Citation

K, W., M, B., M, R., N, A., A, S., F, L., . . . T, S. (2026). Angiotensin-converting enzyme inhibitors vs. receptor blockers in heart failure with mildly reduced ejection fraction. Frontiers in cardiovascular medicine, 13, 1753965. https://doi.org/10.3389/fcvm.2026.1753965

Chicago Style (17th ed.) Citation

K, Weidner, et al. "Angiotensin-converting Enzyme Inhibitors Vs. Receptor Blockers in Heart Failure with Mildly Reduced Ejection Fraction." Frontiers in Cardiovascular Medicine 13 (2026): 1753965. https://doi.org/10.3389/fcvm.2026.1753965.

MLA (9th ed.) Citation

K, Weidner, et al. "Angiotensin-converting Enzyme Inhibitors Vs. Receptor Blockers in Heart Failure with Mildly Reduced Ejection Fraction." Frontiers in Cardiovascular Medicine, vol. 13, 2026, p. 1753965, https://doi.org/10.3389/fcvm.2026.1753965.